סימבין 500 מ"ג - Cymevene 500 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | J05AB Nucleosides and nucleotides excluding reverse transcriptase inhibitors | |||||
|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | ת××-×ר××× - I.V | |||||
| צ×רת ××× ×× | ת×××¡× ×××רק×, SOLUTION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Cymevene IV is indicated for the treatment of CMV retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (AIDS). Cymevene IV is also indicated for the prevention of CMV disease in transplant recipients at risk for CMV disease.
| |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ס××××× 500 ×"× ××××ר ××©×¨× ××ר×××ת
ס×××××× 500 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | HOFFMANN LA ROCHE LTD, SWITZERLAND |
| ×©× ××¢× ×ר×ש×× | TZAMAL BIO-PHARMA LTD |
| ר×ש××× | ת×ר×× ××ש×: 3/1998. ר×ש××× ×ת×ר××: 05/2017 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |
ת××× ×ª ×ר×××